Odyssey Group International, Inc. is a unique, medical device technology holding company publicly traded on the OTCQB under the ticker ODYY.

CardioMap® is one of the products in development intended to capitalize on the multi-billion dollar cardiology market.

We Build and Acquire assets in medical technologies with a substantial market opportunity across the globe.

The Company’s product technologies are diverse, there are three different medical products in development. The Company has two devices being designed for large market segments, one for the cardiology market and one for a home use choking rescue devices. The Company has also partnered with Prevacus, Inc., who has been developing a nasal spray to treat concussions and other brain related medical issues such as Nieman Picks type C disease.